Authors:
RAPER SE
HASKAL ZJ
YE XH
PUGH C
FURTH EE
GAO GP
WILSON JM
Citation: Se. Raper et al., SELECTIVE GENE-TRANSFER INTO THE LIVER OF NONHUMAN-PRIMATES WITH E1-DELETED, E2A-DEFECTIVE, OR E1-E4 DELETED RECOMBINANT ADENOVIRUSES, Human gene therapy, 9(5), 1998, pp. 671-679
Authors:
GAO GP
QU G
FAUST LZ
ENGDAHL RK
XIAO WD
HUGHES JV
ZOLTICK PW
WILSON JM
Citation: Gp. Gao et al., HIGH-TITER ADENOASSOCIATED VIRAL VECTORS FROM A REP CAP CELL-LINE ANDHYBRID SHUTTLE VIRUS/, Human gene therapy, 9(16), 1998, pp. 2353-2362
Citation: Xh. Ye et al., EVALUATING THE POTENTIAL OF GERM-LINE TRANSMISSION AFTER INTRAVENOUS ADMINISTRATION OF RECOMBINANT ADENOVIRUS IN THE C3H MOUSE, Human gene therapy, 9(14), 1998, pp. 2135-2142
Authors:
CHIRMULE N
HUGHES JV
GAO GP
RAPER SE
WILSON JM
Citation: N. Chirmule et al., ROLE OF E4 IN ELICITING CD4 T-CELL AND B-CELL RESPONSES TO ADENOVIRUSVECTORS DELIVERED TO MURINE AND NONHUMAN PRIMATE LUNGS, Journal of virology, 72(7), 1998, pp. 6138-6145
Citation: Gp. Gao et al., BIOLOGY OF ADENOVIRUS VECTORS WITH E1 AND E4 DELETIONS FOR LIVER-DIRECTED GENE-THERAPY, Journal of virology, 70(12), 1996, pp. 8934-8943
Authors:
FISHER KJ
GAO GP
WEITZMAN MD
DEMATTEO R
BURDA JF
WILSON JM
Citation: Kj. Fisher et al., TRANSDUCTION WITH RECOMBINANT ADENOASSOCIATED VIRUS FOR GENE-THERAPY IS LIMITED BY LEADING-STRAND SYNTHESIS, Journal of virology, 70(1), 1996, pp. 520-532
Citation: Gp. Gao et Rj. Herrera, ENRICHMENT OF MIDDLE REPETITIVE ELEMENT BM-1 TRANSCRIPTS IN TRANSLATIONALLY ACTIVE RNA FRACTIONS OF THE SILKMOTH, BOMBYX-MORI, Genetica, 97(2), 1996, pp. 173-182
Authors:
KAUL R
GAO GP
MATALON R
ALOYA M
SU Q
JIN M
JOHNSON AB
SCHUTGENS RBH
CLARKE JTR
Citation: R. Kaul et al., IDENTIFICATION AND EXPRESSION OF 8 NOVEL MUTATIONS AMONG NON-JEWISH PATIENTS WITH CANAVAN DISEASE, American journal of human genetics, 59(1), 1996, pp. 95-102
Authors:
KAUL R
GAO GP
MICHALS K
WHELAN DT
LEVIN S
MATALON R
Citation: R. Kaul et al., NOVEL (CYS152-GREATER-THAN-ARG) MISSENSE MUTATION IN AN ARAB PATIENT WITH CANAVAN DISEASE, Human mutation, 5(3), 1995, pp. 269-271
Authors:
MATALON R
KAUL R
GAO GP
MICHALS K
GRAY RGF
BENNETTBRITON S
NORMAN A
SMITH M
JAKOBS C
Citation: R. Matalon et al., PRENATAL-DIAGNOSIS FOR CANAVAN DISEASE - THE USE OF DNA MARKERS, Journal of inherited metabolic disease, 18(2), 1995, pp. 215-217
Citation: R. Kaul et al., CANAVAN DISEASE - GENOMIC ORGANIZATION AND LOCALIZATION OF HUMAN ASPATO 17P13-TER AND CONSERVATION OF THE ASPA GENE DURING EVOLUTION, Genomics, 21(2), 1994, pp. 364-370
Citation: R. Kaul et al., CANAVAN DISEASE - MOLECULAR-BASIS OF ASPARTOACYLASE DEFICIENCY, Journal of inherited metabolic disease, 17(3), 1994, pp. 295-297
Citation: R. Kaul et al., CLONING OF THE HUMAN ASPARTOACYLASE CDNA AND A COMMON MISSENSE MUTATION IN CANAVAN DISEASE, Nature genetics, 5(2), 1993, pp. 118-123
Authors:
KAUL R
GAO GP
ALOYA M
MICHALS K
MATALON R
Citation: R. Kaul et al., IDENTIFICATION OF MUTATIONS IN HUMAN ASPARTOACYLASE (HASP) GENE IN CANAVAN DISEASE, American journal of human genetics, 53(3), 1993, pp. 215-215